key: cord-0866512-60r30cim authors: Hare, Jonathan; Morrison, David; Nielsen, Morten title: Sampling SARS-CoV-2 proteomes for predicted CD8 T-cell epitopes as a tool for understanding immunogenic breadth and rational vaccine design date: 2020-09-30 journal: bioRxiv DOI: 10.1101/2020.08.15.250647 sha: c19e6196223fd8164e837030ff2a0a8096961c11 doc_id: 866512 cord_uid: 60r30cim Predictive models for vaccine design have become a powerful and necessary resource for the expeditiousness design of vaccines to combat the ongoing SARS-CoV-2 global pandemic. Here we use the power of these predicted models to assess the sequence diversity of circulating SARS-CoV-2 proteomes in the context of an individual’s CD8 T-cell immune repertoire to identify potential. defined regions of immunogenicity. Using this approach of expedited and rational CD8 T-cell vaccine design, it may be possible to develop a therapeutic vaccine candidate with the potential for both global and local coverage. The COVID-19 pandemic is a worldwide health emergency. The first cases were believed to 19 have occurred earlier than December 2019, and as of the middle of September there have been more than 31,000,000 cases of SARS-CoV-2 infection have been reported worldwide and in 21 excess of 965,000 deaths (Update, ecdc.2020) . Vaccine development against SARS-CoV-2 is 22 accelerating, and currently there are more than 130 vaccines in development with some 23 progressing to clinical trials in man (Mullard, 2020) . Of these vaccines the majority are for a 24 prophylactic indication with the spike glycoprotein being the preferred antigen target. The full repertoire of immune responses to COVID-19 in patients is still being evaluated but proteome that could be included within a therapeutic T-cell vaccine. For genes from each SARS-CoV-2 virus proteome sequence all 8-11mer peptides were 54 generated. The binding affinity of each peptide to the HLA alleles described above was predicted 55 using NetMHCpan-4.1. Binding predictions below the peptide conservation threshold were read into PostgreSQLR for 57 analysis. The evaluated set of predicted binders was determined as peptides that appear in any 58 virus proteomes, above the peptide conservation threshold of 2.1%. First the virus proteome with 59 the largest number of unique predicted binders was identified. Next, the proteome that, when 60 combined with the previously selected proteome gave the highest increase in coverage of all 61 predicted peptide binders was included. This iterative process was repeated until 100% of all 62 predicted T-cell epitopes were accounted for. For comparison, set-building was performed a second time using randomly selected proteomes instead of choosing the proteome that resulted in 64 the greatest increase of peptide coverage. For more information go to dataspace.iavi.org Our approach uses NetMHCpan to predict the HLA/peptide binding affinity for the selected 67 virus strains and then identify a set of close binding peptides that are common across the strains. This algorithm was used to analyze 287 SARS-CoV-2 proteome sequences collected between 69 and 08 January and 02 April 2020 and downloaded from NCBI SARS-CoV-2 virus database. Table 1 for input sample data and full model We identified 409 predicted CD8 peptides that have 100% conservation within our sample set 112 with >90% of the predicted epitopes contained within either the ORF1ab polypeptide or spike 113 glycoprotein. Furthermore, the predicted epitopes appear to cluster within a ~550 a.a region of The authors declare that the research was conducted in the absence of any commercial or 137 financial relationships that could be construed as a potential conflict of interest. Characterization of HIV-specific CD4+ T cell responses against peptides 153 selected with broad population and pathogen coverage Broad and 156 strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK Journal Pre-proof Targets of T cell responses to SARS-CoV-2 161 coronavirus in humans with COVID-19 disease and unexposed individuals Selective HLA restriction permits the evaluation and interpretation of immunogenic 168 Sampling SARS-CoV-2 proteomes for predicted 171 CD8 T-cell epitopes as a tool for understanding immunogenic breadth and rationale 2 172 vaccine design. BioRxiv, 2020.08.15.250647 Spike mutation pipeline reveals the emergence of a more transmissible 175 form of SARS-CoV-2 T Cell Responses 178 to Whole SARS Coronavirus in Humans Utilizing Computational Machine Learning Tools to Understand 182 Immunogenic Breadth in the Context of a CD8 T-Cell Mediated 2 HIV Response 3 Utilizing Computational Machine Learning Tools to Understand NetMHCpan-3.0; improved prediction of binding to MHC 190 class I molecules integrating information from multiple receptor and peptide length datasets Analysis of CD8+ T cell response during the 2013-2016 Ebola 194 epidemic in West Africa High crossreactivity of human T cell responses between Lassa virus lineages COVID-19 situation update worldwide, as of 2 Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 Recovery from the Middle East respiratory syndrome is associated with 207 antibody and T cell responses